Minerva Neurosciences Reports Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates
March 13, 2017 07:30 ET
|
Minerva Neurosciences, Inc.
Multiple positive data readouts during 2016 provide foundation for initiation of advanced clinical trials with three product candidates in 2017 Management to host conference call today at...
Minerva Neurosciences to Report Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates on March 13, 2017
March 06, 2017 08:30 ET
|
Minerva Neurosciences, Inc.
WALTHAM, Mass., March 06, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...